Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Diagn Microbiol Infect Dis. 2019 Nov 23;96(2):114953. doi: 10.1016/j.diagmicrobio.2019.114953

Table 3.

Antimicrobial Susceptibilities of Initial and Serial Stenotrophomonas maltophilia Isolates, No. (%)

Ceftazidime Levofloxacin Minocycline TIM SXT Ciprofloxacina Moxifloxacina Tigecyclinea
Initial Isolates (N=71) 30 (42.3) 59 (83.1) 71 (100) 48 (67.6) 70 (98.6) 10 (28.2) 69 (97.2) 62 (87.3)
Serial Isolates (N=26) 1 (3.8) 8 (30.8) 26 (100) 8 (30.8) 21 (80.8) 2 (7.7) 23 (88.5) 6 (23.1)

SXT – trimethoprim-sulfamethoxazole; TIM – ticarcillin-clavulanic acid

a

Susceptibility defined for ciprofloxacin, moxifloxacin, and tigecycline by MIC ≤ 2 μg/ml, ≤ 4 μg/ml, and ≤ 2 μg/ml respectively based on values used in published literature